ARHGAP26 and ovarian cancer: Our results provided evidence, suggesting that ARHGAP26 inhibits ovarian cancer cell invasion and migration in vivo and in vitro, and SMURF1-mediated ARHGAP26 ubiquitination may promote ovarian cancer cell invasion and migration via the β-catenin signaling pathway.